Immune checkpoint inhibitors - Rosalie Stephens

Date Published: 
Tuesday, August 7, 2018

Rosalie Stephens talks about immune checkpoint inhibitors; a new cancer treatment. Rosalie is a medical oncologist specialising in the treatment of patients with melanoma, breast and gynaecological cancers. Rosalie works at Auckland Hospital and is also at the New Zealand melanoma unit in Takapuna.




  • The new class of drugs and which are available in New Zealand.
  • How do these new drugs work?
  • What are the current indications for the immune checkpoint inhibitors?
  • What adverse effects should we be looking for?
  • Keytruda and its treatment for melanoma.


Take home messages

  • These drugs are having a big impact already.
  • Most success has been in advanced melanoma.
  • The drugs are mostly well tolerated.
  • Red flags are anything neurological, diarrhoea, dry cough, shortness of breath.





Rosalie Stephens
Medical Oncologist

To contact Rosalie Click here.

Recognition of Learning Activities

Complete and submit the learning reflection form for CPD/MOPS points provided by The Royal New Zealand College of General Practitioners below for recognition of learning activities.

Learning Reflection Form